Cargando…

Current controversies in radiotherapy for breast cancer

Multimodal treatment approaches have substantially improved the outcome of breast cancer patients in the last decades. Radiotherapy is an integral component of multimodal treatment concepts used in curative and palliative intention in numerous clinical situations from precursor lesions such as ducta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krug, David, Baumann, René, Budach, Wilfried, Dunst, Jürgen, Feyer, Petra, Fietkau, Rainer, Haase, Wulf, Harms, Wolfgang, Piroth, Marc D., Sautter-Bihl, Marie-Luise, Sedlmayer, Felix, Souchon, Rainer, Wenz, Frederik, Sauer, Rolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259946/ https://www.ncbi.nlm.nih.gov/pubmed/28114948 http://dx.doi.org/10.1186/s13014-017-0766-3

Ejemplares similares

DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases
por: Budach, Wilfried, et al.
Publicado: (2015)

Heart toxicity from breast cancer radiotherapy: Current findings, assessment, and prevention
por: Piroth, Marc D., et al.
Publicado: (2018)

DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences
por: Harms, Wolfgang, et al.
Publicado: (2016)

Erratum to: DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases
por: Budach, Wilfried, et al.
Publicado: (2015)

Post-neoadjuvant treatment with capecitabine and trastuzumab emtansine in breast cancer patients—sequentially, or better simultaneously?
por: Piroth, Marc D., et al.
Publicado: (2020)

DEGRO practical guidelines: radiotherapy of breast cancer I: Radiotherapy following breast conserving therapy for invasive breast cancer
por: Sedlmayer, F., et al.
Publicado: (2013)

Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward
por: Krug, David, et al.
Publicado: (2021)

Oligometastasis in breast cancer—current status and treatment options from a radiation oncology perspective
por: Piroth, Marc D., et al.
Publicado: (2022)

DEGRO practical guideline for partial-breast irradiation
por: Strnad, V., et al.
Publicado: (2020)

Reply to: The challenge of cardiac dose constraint adaptation to hypofractionated breast radiotherapy in clinical practice
por: Piroth, Marc D., et al.
Publicado: (2021)

Genetic predictors of acute toxicities related to radiation therapy following lumpectomy for breast cancer: a case-series study
por: Ambrosone, Christine B, et al.
Publicado: (2006)

Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer
por: Chang-Claude, J, et al.
Publicado: (2009)

Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients
por: Brunner, Thomas B, et al.
Publicado: (2011)

Stereotaktische Radiotherapie plus Nivolumab bei NSCLC
por: Krug, David, et al.
Publicado: (2023)

Simultan-integrierter Boost bei moderat hypofraktionierter adjuvanter Radiotherapie der Brust
por: Krug, David, et al.
Publicado: (2023)

Para-aortic irradiation for stage I testicular seminoma: results of a prospective study in 675 patients. A trial of the German testicular cancer study group (GTCSG)
por: Classen, J, et al.
Publicado: (2004)

Intraoperative radiotherapy (IORT) as boost in breast cancer
por: Sedlmayer, Felix, et al.
Publicado: (2017)

Randomisierte, kontrollierte Studie zur palliativen Radiotherapie von Kopf-Hals-Tumoren – Herausforderungen bleiben bestehen
por: Fabian, Alexander, et al.
Publicado: (2020)

Obituary for Herman D. Suit, M.D., D. Phil.
por: Baumann, Michael, et al.
Publicado: (2022)

Region of interest optimization for radiation therapy of breast cancer
por: Sauer, Tim‐Oliver, et al.
Publicado: (2021)

Prerequisites for the clinical implementation of a markerless SGRT-only workflow for the treatment of breast cancer patients
por: Sauer, Tim-Oliver, et al.
Publicado: (2022)

Plan robustness analysis for threshold determination of SGRT-based intrafraction motion control in 3DCRT breast cancer radiation therapy
por: Sauer, Tim-Oliver, et al.
Publicado: (2023)

Treatment of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: German Expert Opinions on the 17th International St. Gallen Consensus Conference
por: Untch, Michael, et al.
Publicado: (2021)

Oesophageal cancer: exploring controversies overview of experts’ opinions of Austria, Germany, France, Netherlands and Switzerland
por: Putora, Paul Martin, et al.
Publicado: (2015)

Boost und Hypofraktionierung beim DCIS
por: Dunst, Jürgen, et al.
Publicado: (2022)

Enzalutamid versus aktive Überwachung bei Patienten mit Low-risk-Prostatakarzinom
por: Dunst, Jürgen, et al.
Publicado: (2022)

No Difference in Overall Survival and Non-Breast Cancer Deaths after Partial Breast Radiotherapy Compared to Whole Breast Radiotherapy—A Meta-Analysis of Randomized Trials
por: Haussmann, Jan, et al.
Publicado: (2020)

Accuracy of MRI-CT registration in brain stereotactic radiotherapy: Impact of MRI acquisition setup and registration method
por: Masitho, Siti, et al.
Publicado: (2022)

Comparison of adverse events in partial- or whole breast radiotherapy: investigation of cosmesis, toxicities and quality of life in a meta-analysis of randomized trials
por: Haussmann, Jan, et al.
Publicado: (2023)

Low-Dose Radiotherapy Has No Harmful Effects on Key Cells of Healthy Non-Inflamed Joints
por: Deloch, Lisa, et al.
Publicado: (2018)

Modern Radiotherapy Concepts and the Impact of Radiation on Immune Activation
por: Deloch, Lisa, et al.
Publicado: (2016)

Keynote Address at the American Society of Breast Surgeons 18th Annual Meeting: Current and Future Application of Intraoperative Radiotherapy (IORT) in the Curative and Palliative Treatment of Breast Cancer
por: Wenz, Frederik
Publicado: (2017)

Vulnerabilitäten bei Radiomics: Warum die populärste Radiomics-Signatur unbemerkt das Tumorvolumen gemessen hat
por: Putz, Florian, et al.
Publicado: (2021)

Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines
por: Rubner, Yvonne, et al.
Publicado: (2014)

12 × 6 Gy stereotactic radiotherapy for lung tumors. Is there a difference in response between lung metastases and primary bronchial carcinoma?
por: Lubgan, Dorota, et al.
Publicado: (2021)

Controversies in the role of radiotherapy in pleural mesothelioma
por: Hanna, Gerard G., et al.
Publicado: (2021)

Adjuvant radiotherapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials
por: Budach, Wilfried, et al.
Publicado: (2013)

Immunotherapy Combined with Large Fractions of Radiotherapy: Stereotactic Radiosurgery for Brain Metastases—Implications for Intraoperative Radiotherapy after Resection
por: Herskind, Carsten, et al.
Publicado: (2017)

Comparing Local and Systemic Control between Partial- and Whole-Breast Radiotherapy in Low-Risk Breast Cancer—A Meta-Analysis of Randomized Trials
por: Haussmann, Jan, et al.
Publicado: (2021)

Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial
por: Krug, David, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lnf6sp5b26h0hl5i8s16p611dp